PortfoliosLab logo
Liquidia Corporation (LQDA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US53635D2027

CUSIP

53635D202

IPO Date

Jul 26, 2018

Highlights

Market Cap

$1.33B

EPS (TTM)

-$1.71

Total Revenue (TTM)

$14.14M

Gross Profit (TTM)

$8.22M

EBITDA (TTM)

-$113.22M

Year Range

$8.26 - $19.41

Target Price

$26.50

Short %

24.32%

Short Ratio

10.79

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Liquidia Corporation (LQDA) returned 30.53% year-to-date (YTD) and 19.55% over the past 12 months.


LQDA

YTD

30.53%

1M

13.28%

6M

44.13%

1Y

19.55%

3Y*

65.76%

5Y*

12.71%

10Y*

N/A

^GSPC (Benchmark)

YTD

-1.34%

1M

7.94%

6M

-2.79%

1Y

10.16%

3Y*

13.76%

5Y*

14.45%

10Y*

10.68%

*Annualized

Monthly Returns

The table below presents the monthly returns of LQDA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202521.00%8.85%-4.78%-5.29%9.88%30.53%
20246.23%10.80%4.17%-12.88%0.16%-6.76%-0.58%-20.28%5.15%8.50%6.45%1.82%-2.24%
20233.61%14.70%-8.72%-2.89%21.01%-3.33%-1.66%-11.01%-7.71%2.68%9.98%68.02%88.85%
202216.22%14.31%10.97%-24.23%-25.37%7.39%12.50%17.64%-5.72%-10.11%2.66%26.89%30.80%
2021-7.12%2.19%-3.93%5.58%5.99%-4.98%-19.58%16.09%3.37%35.87%10.67%17.35%65.08%
202035.91%-28.92%14.04%5.73%85.54%-8.87%-34.32%-7.41%-3.91%-6.10%-39.61%5.73%-30.99%
2019-33.56%39.12%-43.16%-16.43%4.42%-19.44%-8.63%-44.46%-12.32%23.03%-0.68%-1.72%-80.26%
2018-1.26%39.96%78.81%-40.28%36.51%-3.13%95.14%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of LQDA is 63, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of LQDA is 6363
Overall Rank
The Sharpe Ratio Rank of LQDA is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of LQDA is 6161
Sortino Ratio Rank
The Omega Ratio Rank of LQDA is 6363
Omega Ratio Rank
The Calmar Ratio Rank of LQDA is 6363
Calmar Ratio Rank
The Martin Ratio Rank of LQDA is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Liquidia Corporation (LQDA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Liquidia Corporation Sharpe ratios as of May 24, 2025 (values are recalculated daily):

  • 1-Year: 0.32
  • 5-Year: 0.16
  • All Time: 0.06

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Liquidia Corporation compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


Liquidia Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Liquidia Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Liquidia Corporation was 93.87%, occurring on Aug 4, 2021. The portfolio has not yet recovered.

The current Liquidia Corporation drawdown is 58.71%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.87%Oct 10, 2018709Aug 4, 2021
-8.7%Oct 4, 20183Oct 8, 20181Oct 9, 20184
-8.64%Aug 23, 20187Aug 31, 20181Sep 4, 20188
-8.03%Sep 28, 20182Oct 1, 20181Oct 2, 20183
-6.18%Sep 12, 20183Sep 14, 20185Sep 21, 20188

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Liquidia Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Liquidia Corporation, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -7.1%.


-0.50-0.40-0.30-0.20-0.1020212022202320242025
-0.45
-0.42
Actual
Estimate

Valuation

The Valuation section provides an overview of how Liquidia Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for LQDA relative to other companies in the Biotechnology industry. Currently, LQDA has a P/S ratio of 94.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for LQDA in comparison with other companies in the Biotechnology industry. Currently, LQDA has a P/B value of 26.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items